Interpretable Machine Learning Model for Predicting Prolonged Postoperative Length of Stay in Lung Cancer Patients Undergoing Day Surgery: A Retrospective Cohort Study.
[BACKGROUND] Prolonged postoperative length of stay (p-LOS) in lung cancer patients is associated with poorer prognosis and increased healthcare burden, highlighting the need for early identification
APA
Wu X, Lan M, et al. (2026). Interpretable Machine Learning Model for Predicting Prolonged Postoperative Length of Stay in Lung Cancer Patients Undergoing Day Surgery: A Retrospective Cohort Study.. The Journal of craniofacial surgery, 37(3-4), 534-539. https://doi.org/10.1097/SCS.0000000000012152
MLA
Wu X, et al.. "Interpretable Machine Learning Model for Predicting Prolonged Postoperative Length of Stay in Lung Cancer Patients Undergoing Day Surgery: A Retrospective Cohort Study.." The Journal of craniofacial surgery, vol. 37, no. 3-4, 2026, pp. 534-539.
PMID
41773834
Abstract
[BACKGROUND] Prolonged postoperative length of stay (p-LOS) in lung cancer patients is associated with poorer prognosis and increased healthcare burden, highlighting the need for early identification of high risk individuals. This study aimed to develop and validate a machine learning model to predict p-LOS in patients undergoing day surgery for lung cancer.
[METHODS] A retrospective analysis was conducted on 1009 patients who underwent day surgery for lung cancer. Prolonged p-LOS was defined as hospitalization exceeding 48 hours. Feature selection was performed using Lasso regression, and predictive models were developed using 6 machine learning algorithms with internal validation. Model performance was evaluated using AUC and other metrics, and the SHAP method was applied to interpret feature contributions and individual predictions.
[RESULTS] Among the included patients, 128 (12.69%) experienced prolonged p-LOS. The LightGBM model demonstrated optimal performance, achieving an AUC of 0.947 (0.919-0.974). Key predictive factors included fatigue, subcutaneous emphysema, pain, and cough.
[CONCLUSIONS] The developed machine learning model accurately predicts prolonged p-LOS risk in lung cancer patients following day surgery, with high discriminative ability and interpretability. It shows potential for supporting early clinical intervention and optimizing postoperative care.
[METHODS] A retrospective analysis was conducted on 1009 patients who underwent day surgery for lung cancer. Prolonged p-LOS was defined as hospitalization exceeding 48 hours. Feature selection was performed using Lasso regression, and predictive models were developed using 6 machine learning algorithms with internal validation. Model performance was evaluated using AUC and other metrics, and the SHAP method was applied to interpret feature contributions and individual predictions.
[RESULTS] Among the included patients, 128 (12.69%) experienced prolonged p-LOS. The LightGBM model demonstrated optimal performance, achieving an AUC of 0.947 (0.919-0.974). Key predictive factors included fatigue, subcutaneous emphysema, pain, and cough.
[CONCLUSIONS] The developed machine learning model accurately predicts prolonged p-LOS risk in lung cancer patients following day surgery, with high discriminative ability and interpretability. It shows potential for supporting early clinical intervention and optimizing postoperative care.
MeSH Terms
Humans; Retrospective Studies; Machine Learning; Lung Neoplasms; Female; Male; Length of Stay; Middle Aged; Aged; Ambulatory Surgical Procedures; Postoperative Complications
같은 제1저자의 인용 많은 논문 (5)
- Artificial Intelligence Models Integrating Preoperative Prostate MRI and Clinical Parameters for Predicting Extraprostatic Extension: A Systematic Review and Meta-Analysis.
- Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA.
- Development and validation of a predictive and prognostic model of perineural invasion in colorectal cancer.
- Host-microbe interactions in NAD metabolism.
- Multimodal Deep Learning with Routine Clinical Data for Recurrence Risk Stratification in HR/HER2 Early Breast Cancer.